Aeon Biopharma, Inc
AEON Biopharma is a biopharmaceutical company focused on developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions. The company is dedicated to innovation in the rapidly expanding therapeutic botulinum toxin market. This therapeutic-only focus will allow AEON Biopharma to advance safe and effective treatment options to patients, while delivering differentiated economics to payors and physicians. The company continues to evaluate additional therapeutic indications for development based on a comprehensive product assessment process designed to identify those indications where it believes ABP-450 can attain clinical, regulatory and commercial success.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
9
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 8 verified contacts at Aeon Biopharma, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- AW
Alex Wilson
, - · Other
EmailPhone - CL
Christine Ludovico
Executive Director Clinical Operations · Operations
EmailPhone - DT
Dana Testa
Regulatory Scientist · Science
EmailPhone - NA
Najeebah Abdul-Musawir
Senior Medical Director · Healthcare & Human Services
EmailPhone
Showing 4 of 8 verified contacts
Top roles at Aeon Biopharma, Inc
4 distinct titles indexed · top 4 shown.
- 1, -
- 1executive director clinical operations
- 1regulatory scientist
- 1senior medical director
Sign up to unlock all 8 contacts at Aeon Biopharma, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Aeon Biopharma, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.